|
RNF5P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.403500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.875400E-03 |
| Normal-vs-Stage2 |
1.781960E-01 |
| Normal-vs-Stage3 |
7.257200E-01 |
| Normal-vs-Stage4 |
4.791800E-01 |
| Stage1-vs-Stage2 |
7.020600E-01 |
| Stage1-vs-Stage3 |
2.488000E-01 |
| Stage1-vs-Stage4 |
6.761800E-01 |
| Stage2-vs-Stage3 |
5.047000E-01 |
| Stage2-vs-Stage4 |
8.459000E-01 |
| Stage3-vs-Stage4 |
7.302000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.377950E-02 |
| Normal-vs-AfricanAmerican |
3.240100E-04 |
| Normal-vs-Asian |
2.248200E-01 |
| Caucasian-vs-AfricanAmerican |
6.950500E-02 |
| Caucasian-vs-Asian |
3.839200E-01 |
| AfricanAmerican-vs-Asian |
7.598000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.679500E-03 |
| Normal-vs-Female |
7.598800E-03 |
| Male-vs-Female |
7.843400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.461800E-02 |
| Normal-vs-Extreme_Weight |
4.313800E-02 |
| Normal-vs-Obese |
2.223800E-03 |
| Normal-vs-Extreme_Obese |
4.346000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.324000E-01 |
| Normal_Weight-vs-Obese |
4.008000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.991000E-01 |
| Extreme_Weight-vs-Obese |
3.224200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.925400E-01 |
| Obese-vs-Extreme_Obese |
9.132400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.818300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.269800E-02 |
| Normal-vs-Age(61-80Yrs) |
5.502600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.358000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.306200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.713200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.658230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.773400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.477600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.508800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.281900E-03 |
| Normal-VS-Type2 PRCC |
6.696400E-01 |
| Normal-VS-KIRP CIMP |
2.69279999964844E-07 |
| Normal-VS-Unclassified PRCC |
6.875300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.814500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.00129999999854E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.957800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.4247999970467E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
3.904400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.622880E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.329780E-01 |
| Normal-vs-N1 |
1.472960E-01 |
| Normal-vs-N2 |
5.876200E-01 |
| N0-vs-N1 |
7.730600E-01 |
| N0-vs-N2 |
8.847000E-01 |
| N1-vs-N2 |
9.932200E-01 |
|
|
